News
A 68-year-old man with severe PAH and multiple coexisting conditions experienced marked improvement after receiving ...
Yutrepia, prescribed to over 900 PAH or PH-ILD patients since its May U.S. approval, increased walking distances by over 100 ...
A 68-year-old man with severe PAH and multiple coexisting conditions experienced marked improvement after receiving combination therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results